Quest Diagnostics Incorporated

NYSE DGX

Quest Diagnostics Incorporated EBT Margin for the Trailing 12 Months (TTM) ending December 31, 2024: 11.90%

Quest Diagnostics Incorporated EBT Margin is 11.90% for the Trailing 12 Months (TTM) ending December 31, 2024, a -2.55% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

Quest Diagnostics Incorporated EBT Margin for the Trailing 12 Months (TTM) ending December 31, 2023 was 12.21%, a -2.50% change year over year.
Quest Diagnostics Incorporated EBT Margin for the Trailing 12 Months (TTM) ending December 31, 2022 was 12.53%, a -48.00% change year over year.
Quest Diagnostics Incorporated EBT Margin for the Trailing 12 Months (TTM) ending December 31, 2021 was 24.09%, a 20.68% change year over year.
Quest Diagnostics Incorporated EBT Margin for the Trailing 12 Months (TTM) ending December 31, 2020 was 19.96%, a 43.35% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

NYSE: DGX

Quest Diagnostics Incorporated

CEO	Mr. James E. Davis
IPO Date	Dec. 17, 1996
Location	United States
Headquarters	500 Plaza Drive
Employees	50,000
Sector	Healthcare
Industries Telehealth Biotechnology Clinical Trials Drugstores & Retail Pharmacies Health Insurance & Plans Insurance Medical Instruments Pharmaceuticals

Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Key trends

Past 5 years